A Pilot Study of Hemoporfin Photodynamic Therapy in Children (7-14 Years Old) With Port-wine Stain
Phase of Trial: Phase IV
Latest Information Update: 09 Mar 2018
At a glance
- Drugs Hematoporphyrin monomethyl ether (Primary)
- Indications Port-wine stain
- Focus Therapeutic Use
- Sponsors Shanghai Fudan-Zhangjiang Bio-Pharmaceutical
- 06 Mar 2018 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 06 Mar 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
- 12 Jun 2017 Status changed from not yet recruiting to recruiting.